BASSETERRE, St. Kitts — The World Health Organization’s (WHO’s) Strategic Advisory Group of Experts on Immunization (SAGE) has stated that the Oxford/AstraZeneca Vaccine can be used by all adults, even the elderly, worldwide, according to the Financial Times.

“The vaccine can be used by all people over the age of 18 years in all countries,” said Chief Medical Officer, Dr. Hazel Laws. “The WHO recommends an interval of about eight to 12 weeks between the doses. It has been shown that the two-dose efficacy and immunogenicity increase with a longer inter-dose interval.”

“Preliminary evidence of the vaccine, which the Federation is expecting through the COVAX Facility, shows that it is effective against the variant first identified in the United Kingdom,” said Dr. Laws. “This is reassuring.

“Oxford University and AstraZeneca have said that they expect this vaccine to protect against the more severe disease and death caused by the variant that was first identified in South Africa.

“This is also reassuring because preliminary data a few days ago found that from a trial conducted in South Africa last week, that the vaccine had reduced efficacy against mild and moderate disease caused by the variant first identified in South Africa,” said Dr. Laws. “They are saying that it provides you protection against moderate to severe disease.”

“The WHO is expected to issue an emergency use listing for this vaccine as early as February 15),” said Dr. Laws. “This is important because the COVAX Facility can only distribute vaccines that have achieved the WHO emergency use listing. Once this happens, we should be hopeful in terms of expecting our allocation coming out of the COVAX Facility.”

The post AstraZeneca vaccine helps prevent COVID-19 variants, severe symptoms appeared first on The St Kitts Nevis Observer.